Published 30-day Notice

34360

Federal Register / Vol. 81, No. 104 / Tuesday, May 31, 2016 / Notices

This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Allergy, Immunology,
and Transplantation Research Committee.
Date: June 22–23, 2016,
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 4H100
and 3C100, 5601 Fishers Lane, Rockville, MD
20892 (Telephone Conference Call).
Contact Person: James T. Snyder, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities/
Room 3G31B, National Institutes of Health,
NIAID, 5601 Fishers Lane MSC 9834,
Bethesda, MD 20892–9834, (240) 669–5060,
[email protected].
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID Peer Review Meeting.
Date: June 27–29, 2016.
Time: June 27, 2016, 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: Hilton Washington/Rockville,
Jefferson Room, 1750 Rockville Pike,
Rockville, MD 20852.
Time: June 28, 2016, 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: Hilton Washington/Rockville,
Jefferson Room, 1750 Rockville Pike,
Rockville, MD 20852.
Time: June 29, 2016, 8:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: Hilton Washington/Rockville,
Jefferson Room, 1750 Rockville Pike,
Rockville, MD 20852.
Contact Person: Nancy VazquezMaldonado, Ph.D., Scientific Review Officer,
Scientific Review Program, Division of
Extramural Activities, Room 3F52B National
Institutes of Health/NIAID, 5601 Fishers
Lane, MSC 9834, Bethesda, MD 20892–9834,
(240) 669–5044, [email protected].
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS).
Dated: May 24, 2016.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–12649 Filed 5–27–16; 8:45 am]

amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel
Development of a Biosensor-Based Core
Needle Tumor Biopsy Device.
Date: June 2, 2016.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Cancer Institute Shady
Grove 9609 Medical Center Drive, Room
2W030, Rockville, MD 20850 (Telephone
Conference Call).
Contact Person: Kenneth L. Bielat, Ph.D.,
Scientific Review Officer, Research
Technology and Contract Review Branch,
Division of Extramural Activities, National
Cancer Institute, 9609 Medical Center Drive,
Room 7W244, Rockville, MD 20892–9750,
240–276–6373, [email protected].
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS).
Dated: May 24, 2016.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–12662 Filed 5–27–16; 8:45 am]
BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

BILLING CODE 4140–01–P

sradovich on DSK3TPTVN1PROD with NOTICES

National Institutes of Health
DEPARTMENT OF HEALTH AND
HUMAN SERVICES

Submission for OMB review; 30-day
Comment Request;

National Institutes of Health

Request for Human Embryonic Stem
Cell Line To Be Approved for Use in
NIH Funded Research (OD)
SUMMARY: In compliance with the
requirement of Section 3507(a) (1) (D) of
the Paperwork Reduction Act of 1995,
the National Institutes of Health (NIH)

National Cancer Institute; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as

VerDate Sep<11>2014

20:07 May 27, 2016

Jkt 238001

PO 00000

Frm 00052

Fmt 4703

Sfmt 4703

has submitted to the Office of
Management and Budget (OMB) a
request for review and approval of the
information collection instrument listed
below. This proposed information
collection was previously published in
the Federal Register on March 25, 2016,
page 16190 and allowed 60-days for
public comment. No public comments
were received. The purpose of this
notice is to allow an additional 30 days
for public comment. The NIH may not
conduct or sponsor, and the respondent
is not required to respond to, an
information collection that has been
extended, revised, or implemented on or
after October 1, 1995, unless it displays
a currently valid OMB control number.
Direct Comments to OMB: Written
comments and/or suggestions regarding
the item(s) contained in this notice,
especially regarding the estimated
public burden and associated response
time, should be directed to the: Office
of Management and Budget, Office of
Regulatory Affairs, OIRA_submission@
omb.eop.gov or by fax to 202–395–6974,
Attention: NIH Desk Officer.
Comment Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 30-days of the date of
this publication.
FOR FURTHER INFORMATION CONTACT: To
obtain a copy of the data collection
plans and instruments or request more
information on the proposed project
contact: Dr. Ellen Gadbois, Office of
Science Policy, Office of the Director,
NIH, Building 1, Room 218, MSC 0166,
9000 Rockville Pike, Bethesda, MD
20892, or call non-toll-free number (301)
496–9838 or Email your request,
including your address to: gadboisel@
od.nih.gov. Formal requests for
additional plans and instruments must
be requested in writing.
Proposed Collection: Request for
Human Embryonic Stem Cell Line to be
approved for Use in NIH Funded
Research. OMB No. 0925–0601Expiration Date 5/31/2016—ExtensionOffice of Extramural Research (OER),
National Institutes of Health (NIH).
Need and Use of Information
Collection: The form is used by
applicants to request that human
embryonic stem cell lines be approved
for use in NIH funded research.
Applicants may submit applications at
any time.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
2,550.

E:\FR\FM\31MYN1.SGM

31MYN1

34361

Federal Register / Vol. 81, No. 104 / Tuesday, May 31, 2016 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Type of
respondent

Number of
respondents

Average time
per response
( in hours)

Total annual
burden hour

NIH grantees and others with hESC lines .......................................................

50

3

17

2,550

Total ..........................................................................................................

50

150

........................

2,550

Dated: May 24, 2016.
Lawrence A. Tabak,
Deputy Director, National Institutes of Health.
[FR Doc. 2016–12726 Filed 5–27–16; 8:45 am]
BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended
(5 U.S.C. App), notice is hereby given
of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.

sradovich on DSK3TPTVN1PROD with NOTICES

Number of
responses per
respondent

Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel;
Synthesis and Distribution of Opioid and
Related Peptides (7795).
Date: June 28, 2016.
Time: 10:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Telephone
Conference Call).
Contact Person: Lyle Furr, Scientific
Review Officer, Office of Extramural Affairs,
National Institute on Drug Abuse, NIH,
DHHS, Room 4227, MSC 9550, 6001
Executive Boulevard, Bethesda, MD 20892–
9550, (301) 435–1439, lf33c.nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; NonClinical ADME Studies (8931).
Date: July 13, 2016.
Time: 10:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive

VerDate Sep<11>2014

20:07 May 27, 2016

Jkt 238001

Boulevard, Rockville, MD 20852 (Telephone
Conference Call).
Contact Person: Lyle Furr, Scientific
Review Officer, Office of Extramural Affairs,
National Institute on Drug Abuse, NIH,
DHHS, Room 4227, MSC 9550, 6001
Executive Boulevard, Bethesda, MD 20892–
9550, (301) 435–1439, lf33c.nih.gov.
(Catalogue of Federal Domestic Assistance
Program No.: 93.279, Drug Abuse and
Addiction Research Programs, National
Institutes of Health, HHS).
Dated: May 24, 2016.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–12647 Filed 5–27–16; 8:45 am]
BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: CVRS New Investigator.
Date: June 22, 2016.
Time: 10:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Margaret Chandler, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4126,
MSC 7814, Bethesda, MD 20892, (301435–
1743, [email protected].

PO 00000

Frm 00053

Fmt 4703

Sfmt 4703

Name of Committee: Interdisciplinary
Molecular Sciences and Training Integrated
Review Group; Enabling Bioanalytical and
Imaging Technologies Study Section.
Date: June 23–24, 2016.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hotel Kabuki, 1625 Post Street, San
Francisco, CA 94115.
Contact Person: Kenneth Ryan, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3218,
MSC 7717, Bethesda, MD 20892, 301–435–
0229, [email protected].
Name of Committee: Oncology 2—
Translational Clinical Integrated Review
Group;Cancer Immunopathology and
Immunotherapy Study Section.
Date: June 23–24, 2016.
Time: 8:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Embassy Row Hotel, 2015
Massachusetts Avenue NW., Washington, DC
20036.
Contact Person: Denise R. Shaw, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6158,
MSC 7804, Bethesda, MD 20892, 301–435–
0198, [email protected].
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Review of
Neuroscience AREA Grant Applications.
Date: June 23–24, 2016.
Time: 8:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: DoubleTree by Hilton, 1515 Rhode
Island Avenue NW., Washington, DC 20005.
Contact Person: Richard D. Crosland,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4190,
MSC 7850, Bethesda, MD 20892, 301–435–
1220, [email protected].
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Biomedical Sensing, Measurement
and Instrumentation.
Date: June 24, 2016.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Washington/Rockville, 1750
Rockville Pike, Rockville, MD 20852.
Contact Person: Inna Gorshkova, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, 301–435–1784, [email protected].

E:\FR\FM\31MYN1.SGM

31MYN1